Oral submucous fibrosis patients have altered levels of cytokine production

Journal of Oral Pathology and Medicine

Volumn 29, Issue 3, 2000, Pages 123-128

  Hague, M F ^a   Meghji, Sajeda ^a   Khitab, U ^a   Harris, M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cytokines; Interferon gamma; Oral submucous fibrosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BETEL NUT; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CAUCASIAN; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; HUMAN; IMMUNOLOGY; INDIA; MEDICINAL PLANT; METABOLISM; MOUTH DISEASE; UNITED KINGDOM;

ARECA; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUROPEAN CONTINENTAL ANCESTRY GROUP; GREAT BRITAIN; HUMANS; INDIA; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; ORAL SUBMUCOUS FIBROSIS; PLANTS, MEDICINAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034057935     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2000.290304.x     Document Type: Article

References (38)

1. Canniff JP, Harvey W, Harris M. Oral submucous fibrosis - its pathogenesis and management. Br Dent J 1986; 160: 429-34.
2. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 1966; 22: 764-99.
3. Holdsworth DK, Jones RA, Self R. Volatile alkaloids from Areca catechu. Photochemistry 1998; 48: 581-2.
4. Harvey W, Scutt A, Meghji S, Canniff JP. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 1986; 31: 45-9.
5. Meghji S, Scutt A, Harvey W, Canniff JP. An in vitro comparison of human-fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol 1987; 32: 213-5.
6. Wang CK, Lee WH, Peng CH. Contents of phenolics and alkaloids in Areca catechu Linn during maturation. J Agricult Food Chem 1997; 45: 1185-8.
7. Scutt A, Meghji S, Canniff JP, Harvey W. Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia 1987; 3: 391-3.
8. Canniff JP, Harvey W. The aetiology of oral submucous fibrosis - the stimulation of collagen-synthesis by extracts of areca nut. Int J Oral Surg 1981; 10: 163-7.
9. Maher R, Lee AJ, Warnakulasuriya KS, Lewis JA, Johnson NW. Role of areca nut in the causation of oral submucous fibrosis - a case-control study in Pakistan. J Oral Pathol Med 1994; 23: 65-9.
10. Canniff JP, Batchelor JR, Dodi IA, Harvey W. HLA-typing in oral submucous fibrosis. Tissue Antigens 1985; 26: 138-42.
11. Kovacs EJ. Fibrogenic cytokines - the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17-23.
12. Schmidt JA, Mizel SB, Cohen D, Green I. Interleukin-1, a potential regulator of fibroblast proliferation. J Immunol 1982; 128: 2177-82.
13. Vilcek J, Palombella VJ, Henriksendestefano D, et al. Fibroblast growth enhancing activity of tumour necrosis factor and its relationship to other polypeptide growth-factors. J Exp Med 1986; 163: 632-43.
14. Piguet PF, Grau GE, Vassalli P. Subcutaneous perfusion of tumour necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal-cells, or massive tissue necrosis. Am J Pathol 1990; 136: 103-10.
15. Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J Rheumatol 1998; 25: 308-13.
16. Ziegenhagen MW, Zabel P, Zissel G, Schlaak M, Muller-Quernheim J. Serum level of interleukin 8 is elevated in idiopathic pulmonary fibrosis and indicates disease activity. Am J Resp Crit Care Med 1998; 157: 762-8.
17. Desmouliere A, Rubbiabrandt L, Abdiu A, Walz T, Macieiracoelho A, Gabbiani G. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res 1992; 201: 64-73.
18. Needleman BW, Wigley FM, Stair RW. Interleukin-1, interleukin-2, interleukin-4, interleukin-6, tumour-necrosis-factor-alpha, and interferon-gamma levels in sera from patients with scleroderma. Arthritis Rheum 1992; 35: 67-72.
19. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992; 12: 300-8.
20. Granstein RD, Deak MR, Jacques SL, et al. The systemic administration of gamma-interferon inhibits collagen-synthesis and acute-inflammation in a murine skin wounding model. J Invest Dermatol 1989; 93: 18-27.
21. Mizel SB. The interleukins. FASEB J 1989; 3: 2379-88.
22. Zhang Y, Lee TC, Guillemin B, Yu MC, Rom WN. Enhanced il-1-beta and tumour-necrosis-factor-alpha release and messenger-RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993; 150: 4188-96.
23. Krane SM, Dayer JM, Simon LS, Byrne MS. Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin-1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial-cells - effects of prostaglandin-e2 and indomethacin. Collagen Related Res 1985; 5: 99-117.
24. Brenner DA, O'Hara M, Angel PCM, Karin M. Prolonged activation of jun and collagenase genes by tumour necrosis factor-α. Nature 1989; 337: 661-3.
25. Dayer JM, de Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest 1986; 77: 645-8.
26. Mauviel A, Heino J, Kahari VM, et al. Comparative effects of interleukin-1 and tumor-necrosis-factor-alpha on collagen production and correspending procollagen messenger-RNA levels in human dermal fibroblasts. J Invest Dermatol 1991; 96: 243-9.
27. Chou DI, Lee W, McCulloch CG. TNF-alpha inactivation of collagen receptors - implications for fibroblast function and fibrosis. J Immunol 1996; 156: 4354-62.
28. Roth M, Nauck M, Tamm M, Perruchoud AP, Ziesche R, Block LH. Intracellular interleukin-6 mediates platelet-derived growth factor-induced proliferation of nontransformed cells. Proc Natl Acad Sci USA 1995; 92: 1312-6.
29. Greenwel P, Iraburu MJ, Reyesromero M, et al. Induction of an acute-phase response in rats stimulates the expression of alpha-1(I) procollagen messenger-ribonucleic-acid in their livers - possible role of interleukin-6. Lab Invest 1995; 72: 83-91.
30. Mallat A, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. Interferon-α and interferon-γ inhibit proliferation and collagen-synthesis of human site cells in culture. Hepatology 1995; 21: 1003-10.
31. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 1998; 66: 713-9.
32. Haque MF, Harris M, Meghji S, Speight PM. An immunohistochemical study of oral submucous fibrosis. J Oral Pathol Med 1997; 26: 75-82.
33. van Wyk CW, Rabie AFG, Martell RW, Hammand MG. HLA antigens in oral submucous fibrosis. J Oral Path Med 1994; 23: 23-7.
34. Saeed B, Haque MF, Meghji S, Harris M. HLA-typing in oral submucous fibrosis. J Dent Res 1997; 76: 41: 1024 (abstr).
35. Saeed B, Haque MF, Meghji S, Harris M. HLA-typing in oral submucous fibrosis. Oral Dis 1997; 3: 156: S39 (abstr).
36. Harris M, Haque MF, Meghji S. Interferon gamma reverses oral submucous fibrosis (OSF). Oral Dis 1997; 3(2): 43 (abstr).
37. Larrabee WF, East CA, Jaffe HS, Stephenson C, Peterson KE. Intralesional interferon gamma-treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159-62.
38. van Wyk CW, Stander I, Padayachee A, Groblerrabie AF. The areca nut chewing habit and oral squamous-cell carcinoma in South-African Indians - a retrospective study. S Afr Med J 1993; 83: 425-9.